Casa
scp 666 1/2 j

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Visualizing lipid receptor localization and activation. (A) CB1 and CB2
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Modulation of the Endocannabinoid System in Cardiovascular Disease
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Frontiers Cannabis: a multifaceted plant with endless potentials
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Estrogen actions in the nervous system
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Biomedicines, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Interactions of leptin and ghrelin with the endocannabinoid system
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
IJMS, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
JCM, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Overview of the endocannabinoid system. The central oval encompasses
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Full article: At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk
de por adulto (o preço varia de acordo com o tamanho do grupo)